Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
reports
BioRestorative Therapies (BRTX) Stock Price & Analysis
79 Followers
BRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.46 - $6.33
Previous Close$5.35
Volume15.84K
Average Volume (3M)30.04K
Market Cap
$20.80M
Enterprise Value$8.69M
Total Cash (Recent Filing)$12.37M
Total Debt (Recent Filing)$268.36K
Price to Earnings (P/E)-1.0
Beta0.76
Next Earnings
May 15, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.28
Shares Outstanding3,887,615
10 Day Avg. Volume23,018
30 Day Avg. Volume30,037
Standard Deviation22.00
R-Squared0.02
Alpha2.20
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)664.50
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue64.35
Enterprise Value/Gross Profit72.56
Enterprise Value/Ebitda-1.10
Forecast
1Y Price Target
$6.00Price Target Upside12.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
BioRestorative Therapies News
BRTX FAQ
What was BioRestorative Therapies’s price range in the past 12 months?
BioRestorative Therapies lowest stock price was $2.46 and its highest was $6.33 in the past 12 months.
What is BioRestorative Therapies’s market cap?
Currently, no data Available
When is BioRestorative Therapies’s upcoming earnings report date?
BioRestorative Therapies’s upcoming earnings report date is May 15, 2018 which is 1846 days ago.
How were BioRestorative Therapies’s earnings last quarter?
Currently, no data Available
Is BioRestorative Therapies overvalued?
According to Wall Street analysts BioRestorative Therapies’s price is currently Undervalued.
Does BioRestorative Therapies pay dividends?
BioRestorative Therapies does not currently pay dividends.
What is BioRestorative Therapies’s EPS estimate?
BioRestorative Therapies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioRestorative Therapies have?
BioRestorative Therapies has 3,887,615 shares outstanding.
What happened to BioRestorative Therapies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioRestorative Therapies?
Currently, no hedge funds are holding shares in BRTX
---
BioRestorative Therapies Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (12.15% Upside)
$6.00 (12.15% Upside)
Insider Transactions
Bought Shares
Worth $2.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.87%
12-Months-Change
Fundamentals
Return on Equity
-115.11%
Trailing 12-Months
Asset Growth
-32.69%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
BioRestorative Therapies
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
---
Top 5 ETFs holding BRTX
Vanguard Total Stock Market ETF
$496.29K
Up to five ETFs with an Outperform Smart Score that hold BRTX. The ETFs are listed according to market value of BRTX within the ETF
---
---